Immunologic Deficiency Syndromes  >>  Octagam (intravenous normal human immunoglobulin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octagam (intravenous normal human immunoglobulin) / Octapharma
NCT00811174 / 2007-002611-27: Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases

Terminated
3
5
Europe
Octagam 10%
Octapharma
Immunologic Deficiency Syndromes
09/10
09/10

Download Options